scholarly journals Endoscopic correction of primary vesicoureteric reflux: results in 94 ureters.

BMJ ◽  
1986 ◽  
Vol 293 (6559) ◽  
pp. 1404-1406 ◽  
Author(s):  
B O'Donnell ◽  
P Puri
2007 ◽  
Vol 3 ◽  
pp. S16
Author(s):  
Ramnath Subramaniam ◽  
Alexander Turner ◽  
Grigorius Kousidis ◽  
David Thomas ◽  
Sally Feather

Author(s):  
David F.M. Thomas

The term vesicoureteric reflux (VUR) describes the retrograde flow of urine from the bladder into the upper urinary tract. VUR is not a disease entity in its own right. Nevertheless, it has the potential to cause significant morbidity by preventing effective emptying of the urinary tract and by facilitating the transport of bacteria into the upper tract and renal parenchyma. Mechanisms of renal damage associated with VUR include pyelonephritic scarring and congenital dysplasia or hypoplasia. The long-term complications of pyelonephritic scarring may include hypertension, renal failure, and an increased risk of complications during pregnancy. VUR of mild or moderate severity is best managed conservatively and surgical intervention is generally reserved for failed medical management and high grade or complex VUR. Although the introduction of endoscopic correction has revolutionized surgical management, there remains a role for open surgery for the correction of higher grades of reflux.


2008 ◽  
Vol 2008 ◽  
pp. 1-5
Author(s):  
Sumit Dave ◽  
Darius J. Bägli

The current literature suggests that multiple variables affect vesicoureteric reflux (VUR) resolution rates following dextranomer/hyaluronic acid copolymer (Dx/HA) injection. This article reviews the evidence pertaining to the effect of injected Dx/HA volume on success rates following endoscopic correction. Lack of prospective studies which use injected volume as a continuous variable coupled with a nonstandardized injection technique and endpoint hinders the ability to reach a definite conclusion.


Sign in / Sign up

Export Citation Format

Share Document